Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
28.42
-1.49 (-4.98%)
BSENSE

Dec 05

BSE+NSE Vol: 1.63 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

No Fixed Assets in the last few periods;

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024

Compare Balance Sheet Results of Kabra Drugs
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
10.00
13.71
137.10%
Share Warrants & Outstandings
Total Reserve
0.95
24.11
-23.16
-96.06%
Shareholder's Funds
24.65
34.11
-9.46
-27.73%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
1.31
-1.31
-100.00%
Secured Loans
0.00
1.31
-1.31
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.64
-0.64
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.18
-0.18
-100.00%
Long Term Provisions
0.00
2.72
-2.72
-100.00%
Total Non-Current Liabilities
0.00
4.84
-4.84
-100.00%
Current Liabilities
Trade Payables
0.00
3.41
-3.41
-100.00%
Other Current Liabilities
0.14
2.67
-2.53
-94.76%
Short Term Borrowings
0.44
13.55
-13.11
-96.75%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.57
19.62
-19.05
-97.09%
Total Liabilities
25.23
58.58
-33.35
-56.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
39.25
-39.20
-99.87%
Less: Accumulated Depreciation
0.01
27.71
-27.70
-99.96%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
11.54
-11.50
-99.65%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.00
-2.00
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
2.25
-2.25
-100.00%
Long Term Loans & Advances
0.02
0.08
-0.06
-75.00%
Other Non Current Assets
0.00
9.29
-9.29
-100.00%
Total Non-Current Assets
0.07
25.16
-25.09
-99.72%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
19.13
-19.13
-100.00%
Sundry Debtors
0.60
12.67
-12.07
-95.26%
Cash and Bank
21.30
0.22
21.08
9,581.82%
Other Current Assets
0.00
0.28
-0.28
-100.00%
Short Term Loans and Advances
3.26
1.13
2.13
188.50%
Total Current Assets
25.16
33.42
-8.26
-24.72%
Net Current Assets (Including Current Investments)
24.59
13.80
10.79
78.19%
Total Current Assets Excluding Current Investments
25.16
33.42
-8.26
-24.72%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
58.58
-33.35
-56.93%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
14.86
-14.42
-97.04%
Book Value per share (adjusted)
10.40
34.11
-23.71
-69.51%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025

Figures in Cr
stock-summary

No Fixed Assets in the last few periods;

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024